Skip to main content

Latest Advances In Orthopaedics

Arthritis A condition causing joint pain and inflammation affecting millions worldwide. While there are several types of arthritis, including osteoarthritis, rheumatoid arthritis, and gout, some common symptoms include joint pain, stiffness, and swelling.
Osteoarthritis It is often caused by joint cartilage's gradual wear and tear over time while the immune system mistakenly attacks the joints. Conversely, gout is caused by the accumulation of uric acid crystals in the joints. Common symptoms of arthritis include stiffness (particularly in the morning), swelling, and warmth around the affected joints. Causes Orthopaedic surgery is one of the most dynamic medical specialities, with rapid and innovative advances in treatment and surgery. In a multicenter series of 347 non-selected TKA patients using various implants, only 62% were pain-free during gait, and 35% were pain-free whilst climbing or running. Symptoms Therefore, although TKA is already an effective surgery, the aim is now to improve patient satisfaction and functional outcomes. Different types of new technologies have been developed to enhance surgical accuracy, and as a result, the hope is that there will be an improvement in patient satisfaction after TKA. New Technologies Dr Praveen Nandwana, Senior Consultant Joint Replacement (Hip and Knee), MBBS, DNB (Orthopedics), HCG Hospitals, Ahmedabad, shares that recently, promising new technologies have been developed in knee arthroplasty and could improve the functional outcomes.
Labels:

Comments

Post a Comment

Popular posts from this blog

Ignoring influenza and flu in winter can be Dangerous

Ignoring influenza (the flu) and flu-like symptoms during the winter can indeed be dangerous. Influenza is a viral infection that primarily spreads through respiratory droplets when an infected person coughs or sneezes. It tends to be more prevalent during the colder months, which is why it's often associated with winter. Here are some reasons why ignoring the flu in winter can be dangerous: Complications: The flu can lead to serious complications, especially in vulnerable populations such as young children, the elderly, pregnant women, and individuals with weakened immune systems. Complications can include pneumonia, bronchitis, sinus infections, and ear infections. Spread of the Virus: Influenza is highly contagious, and neglecting symptoms can contribute to the spread of the virus to others. This is particularly concerning in crowded places like schools, offices, and public transportation. Weakened Immune System: The winter season itself can weaken the immune system, making ...
Post a Comment
Read more

What Is a Secondary Headache?

A secondary headache is a type of headache that is a symptom of another underlying medical condition or disease. Unlike primary headaches, which are not associated with any underlying cause, secondary headaches are a result of an identifiable and usually serious underlying problem. There are numerous potential causes of secondary headaches, including: Head Injury: Traumatic head injuries can lead to headaches as a symptom. Sinusitis: Inflammation of the sinuses can cause pain and pressure in the head. Migraines: While migraines can be primary headaches, they can also be secondary if they are triggered by an underlying condition. Medication Overuse: Excessive use of pain medications, especially those containing caffeine or codeine, can lead to rebound headaches. Infection: Various infections, such as meningitis, encephalitis, or a sinus infection, can cause secondary headaches. High Blood Pressure: Hypertension (high blood pressure) can lead to headaches, especially if it is seve...
Post a Comment
Read more

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is mad...
Post a Comment
Read more